Naval Medical Research Command (NMRC) in partnership with medical device company, RevMedx, developed the XSTAT P15, an advanced hemostatic device designed to control severe bleeding in narrow entrance wounds such as those caused by gunshots or shrapnel. This device uses miniature sponges that expand rapidly to exert pressure onto the wound site and can be easily removed during surgery. NMRC, headquarters of Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. (U.S. Navy photo by Aleece Williams/Released)
| Date Taken: | 01.09.2026 |
| Date Posted: | 01.12.2026 15:38 |
| Photo ID: | 9476566 |
| VIRIN: | 260109-N-AJ766-1003 |
| Resolution: | 1428x889 |
| Size: | 408.33 KB |
| Location: | SILVER SPRING, MARYLAND, US |
| Web Views: | 11 |
| Downloads: | 2 |
This work, NMRC Receives 510(k) Clearance for XSTAT P15 Wound Treatment Device [Image 4 of 4], by Aleece Williams, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
NMRC Receives 510(k) Clearance for XSTAT P15 Wound Treatment Device
No keywords found.
